A B S T R A C T The effect of beta adrenergic stimulation on renal-diluting capacity was examined in the dog. Beta adrenergic stimulation with intravenous isoproterenol significantly increased urinary osmolality (Uo.m) and decreased free water clearance (CH:}O), and these effects were rapidly reversible with cessation of the infusion. This antidiuretic effect of systemic beta adrenergic stimulation was comparable in innervated and denervated kidneys and was not associated with alterations in glomerular filtration rate or renal vascular resistance. Renal perfusion pressure was maintained constant in all of the experiments. The same dose of isoproterenol, which produced the antidiuretic effect and markedly stimulated cardiac beta adrenergic receptors when infused intravenously, was not found either to increase Uosm or to decrease CH2O when infused directly into the renal artery. Removal of the source of production and release of antidiuretic hormone (ADH) was, however, found to abolish the effect of intravenous isoproterenol on Uoar. A small effect on CH20 persisted and appeared to be related to an increase in arterial hematocrit. Thus, the results of the study exclude a major role of alterations in renal hemodynamics and renal innervation in the antidiuretic response to betaadrenergic stimulation with isoproterenol. They also provide no support for the hypothesis that beta adrenergic stimulation may directly alter the water permeability of the renal tubular epithelium. Rather the results suggest that the primary mechanism of the antidiuretic effect of beta adrenergic stimulation involves the integrity of the hypothalamoneurohypophyial system and the release of ADH.
INTRODUCTION
There is now a considerable amount of experimental evidence which suggests that the adrenergic nervous sysDr. Schrier is an Established Investigator of the American Heart Association.
Received for publication 13 July 1971. tem is involved in the control of water metabolism. The results of studies in humans (1) (2) (3) (4) , rats (5, 6) , and the toad bladder (7, 8) have suggested that alpha adrenergic stimulation may antagonize the action of vasopressin at the cellular level. This is an attractive hypothesis since the effect of vasopressin appears to be mediated by adenyl cyclase, an enzyme which in several tissues has been shown to be inhibited by alpha adrenergic stimulation and activated by beta adrenergic stimulation (9, 10) .
Further support for this hypothesis is derived from studies in the rat (11) (12) (13) and cat (14) , which have demonstrated that beta adrenergic stimulation with intravenous isoproterenol is associated with an antidiuretic response. In most of these studies, however, the interpretation of the mechanism responsible for this antidiuretic effect has been complicated by simultaneous decreases in renal perfusion pressure and glomerular filtration rate, which by themselves may influence renaldiluting capacity (15, 16 ).
The present investigation was therefore undertaken to examine the mechanism of the antidiuretic effect of beta adrenergic stimulation and in particular to differentiate between a direct effect on the renal tubule, an effect mediated by alterations in renal hemodynamics and an effect mediated by an extrarenal mechanism involving the release of antidiuretic hormone (ADH) . ' The results demonstrate that an extrarenal reflex involving the integrity of the hypothalamo-neurohypophysial system and the release of ADH is primarily responsible for the antidiuretic effect of systemic beta adrenergic stimulation. The results also excluded a major role of alterations in renal hemodynamics and renal sympathetic tone in this antidiuretic response. Moreover, no experimental evidence was obtained to support a direct effect of beta [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] kg. In these animals food was withheld 18 hr before study, but water was allowed ad lib. On the day of study the animals were anesthetized with intravenous pentobarbital (30 mg/kg), intubated, and ventilated with a Harvard respirator. Light anesthesia was maintained throughout the experiment by the intermittent administration of pentobarbital. All animals received 5 mg of deoxycorticosterone acetate intramuscularly. In five animals hypophysectomy and destruction of hypothalamic neural pathways2 were performed through a buccal approach, after which these animals received 1 mg of dexamethasone intramuscularly. In all animals a solution of 2.5% glucose and water was then infused through a catheter in a foreleg vein at 20 ml/min for 50 min during which time the following surgery was performed. Polyethylene catheters were placed in both ureters and renal veins through bilateral flank incisions. Denervation was performed in some of the kidneys by stripping and severing the renal nerves and then applying 95% alcohol to the renal pedicle. In seven animals with an intact hypothalamo-neurohypophysial system, a 23 gauge needle was placed in the left renal artery. Instruments dye dilution pump. After completion of surgery, an intravenous infusion of 2.5% glucose (0.5 ml/min) was started which contained sufficient inulin and p-aminohippuric acid (PAH) to maintain blood levels of these substances between 15 and 25 and 1 and 3 mg/100 ml, respectively. After 1 liter of 2.5% glucose had been infused, the rate was decreased to 4 ml/min above urine flow. If within an hour after completion of the surgery the urine osmolality was not less than 100 mOsm/kg, an additional 600 ml of 2.5% glucose and water was administered over 30 min, and the infusion rate was again decreased to 4 ml/min above urine flow. No experiment was performed in those animals in which the urine osmolality remained above 100 mOsm/kg 1-li hr after the second water load, with the exception of one kidney each in two animals which had urinary osmolalities of 107 and 108 mOsm/kg H20. After stabilization of urine flow the experiment.was started. Urine was collected at 5-or 10-min intervals throughout the experiment, and (Table II, experiment 5), the aortic clamp was used only to prevent an increase in renal perfusion pressure after cessation of the infusion.
The following experimental protocol was used for both the studies in animals with and without an intact hypothalamo-neurohypophysial tract. After three to five control periods, isoproterenol was infused intravenously and after an equilibration period of 10-20 min, three to five experimental urine collections were made. The infusion of isoproterenol was then discontinued, and after an equilibration period of 10-20 min three to five postcontrol urine collections were made.
Unilateral infusion of isoproterenol into the renal artery. Preliminary experiments were performed in an effort to find a dose of isoproterenol infused into the renal artery which would not alter systemic hemodynamics (as judged by changes in cardiac output and arterial pressure) and yet deliver, a concentration of the drug to the renal circulation, which was at least as high, and preferably higher, than the concentration reaching the renal circulation during Table I and are qualitatively quite similar. In some of these experiments, the intravenous isoproterenol infusion was associated with a fall in systemic arterial pressure; however, in all of the studies the renal perfusion pressure was constant throughout the experiments. In Fig. 2 is shown a representative experiment of the effect of an intravenous infusion of isoproterenol in an animal with ablation of the hypothalamo-neurohypophysial tract. In contrast to the experiments in the intact animals, the intravenous infusion of isoproterenol was not associated with either an increase in U0om or a decrease in CH2O in this experiment. The results of all the experiments in the animals with ablation of the hypophysialhypothalamic neural system are shown in Table II . Although the mean control cardiac output in these animals was similar to the intact animals, the mean control systemic arterial pressure and thus total peripheral resistance was lower. This lower systemic arterial pressure was also associated with lower control levels of glomerular filtration rate and renal blood flow. These control blood pressures and renal hemodynamics in this group of animals were however within a range frequently observed in the normal dog. Although a small but significant increase in mean Uo8s occurred during the intravenous infusion of isoproterenol in this group of animals, the Uos. did not decrease after cessation of the infusion. A small and reversible effect on CH20 was observed during the intravenous infusion of isoproterenol in these animals with ablation of their hypothalamoneurohypophysial system. However, a marked difference was observed between the effect of intravenous isoproterenol on Uoar and CH20 in these animals versus the intact animals, and this difference is illustrated in Fig. 3 (Fig. 4, Table III ). In contrast to the significant effects of intravenous isoproterenol on cardiac output and total peripheral resistance, when the same dose of the drug was infused into the renal artery, these systemic effects of the drug were not observed (Fig.  4) . In these experiments neither cardiac output nor arterial pressure were altered by intrarenal isoproterenol. Cardiac output was 3.9 +0.4, 3.8 ±0.3, and 3.6 ±0.3 liters/min before, during, and after the intrarenal infusion of isoproterenol, and the arterial pressures during these same periods were 137 ±6, 133 +6, and 133 ±7 mm Hg. Arterial hematocrit was not affected by the intrarenal infusion of isoproterenol. The plasma protein concentration declined slightly throughout the experiment from 5.3 to 5.1 to 4.9 g/100 ml before, during, and after the intrarenal infusion, respectively. Despite the higher intrarenal concentration of the drug in these experiments, the infusion of isoproterenol into the renal artery was not associated with significant and reversible effects on renal hemodynamics, CH2O, and Uoar of the infused kidney (Table III) . A small increase in CH2O did occur during the infusion but did not diminish significantly after cessation of the infusion. Analysis of the ratio of the infused over the contralateral kidney revealed a small but significant and reversible effect on CH2O, GFR, and RVR (Table III) . DISCUSSION Robison, Butcher, and Sutherland (18) recently proposed that adenyl cyclase may be a beta adrenergic receptor. This suggestion was based on the findings that beta adrenergic stimulation increases adenyl cyclase activity in certain tissues (9, 10) . In this context, the adrenergic nervous system could be an important regulator of the water permeability of the diluting segment of the mammalian nephron since the effect of vasopressin appears to be mediated by increasing the activity of adenyl cyclase which catalyzes the formation of 3',5'-adenosine monophosphate (cyclic AMP) (19) (20) (21) .
In support of the possibility that renal adenyl cyclase is a beta adrenergic receptor is the finding that the intravenous administration of the potent beta adrenergicstimulating substance, isoproterenol, is known to be associated with an antidiuresis (11) (12) (13) (14) , while the intravenous administration of the alpha adrenergic-stimulating catecholamine, norepinephrine, is known to inhibit the antidiuretic effect of vasopressin (1-6). Moreover, the effect of norepinephrine in humans has been shown to occur in the absence of changes in filtration rate and renal plasma flow and has been shown to be dose related, thus suggesting a competitive inhibition at the site of the renal tubule epithelial cell (1) . On the other hand, in most studies in which an antidiuretic effect of isoproterenol has been demonstrated, a fall in renal perfusion pressure has been consistently observed (11) (12) (13) (14) , and when measured, glomerular filtration rate has also frequently been observed to diminish (11) (12) (13) (14) . Since the simultaneous decrease in renal perfusion pressure and glomerular filtration rate are known to affect renal-diluting ability (15, 16) , the results of these previous studies do not distinguish between a direct effect of isoproterenol on the water permeability of the distal nephron and an effect mediated by alterations in renal hemodynamics. Moreover, in the presence of a decrease in systemic arterial pressure the release of ADH may account entirely for, or at least contribute to, the antidiuretic effect of beta adrenergic stimulation. The purpose of the present investigation was to examine these different possible mechanisms which might account for the antidiuretic effect associated with beta adrenergic stimulation.
In the present study a considerably smaller dose by body weight of intravenous isoproterenol than has been previously used in the rat and cat (11) (12) (13) (14) to be associated with a consistent antidiuretic effect in the dog. Even with this dose of intravenous isoproterenol either a transient or sustained fall in systemic arterial pressure was frequently observed. In order to avoid -any direct renal effect of these changes in arterial pressure, the renal perfusion pressure was maintained constant in all of the present experiments. With this experimental design, the antidiuretic effect of systemic beta adrenergic stimulation was clearly demonstrated to occur independent of any decrease in renal perfusion pressure. It should be emphasized however, that if allowed to occur, any decrease in renal perfusion pressure during an intravenous isoproterenol infusion could contribute to the resulting antidiuretic effect, particularly by decreasing the rate of free water clearance. A role of the renal nerves in the antidiuretic effect of beta adrenergic stimulation was also excluded by the present results, since no consistent quantitative differences in the antidiuretic effect could be observed between the innervated and denervated kidneys (Fig. 3 , Table I ). We can not exclude, however, the possibility that the fall in systemic arterial pressure during intravenous isoproterenol was associated with a baroreceptormediated increase in renal sympathetic tone which was obscured by the direct renal-vasodilating effect of the drug (22, 23) . If present, such an effect of increased renal sympathetic tone would have to be mediated by circulating catecholamines in the denervated kidneys.
In any case, since no significant change in renal vascular resistance was observed in either the denervated or innervated kidneys, the antidiuretic effect associated with the intravenous infusion of isoproterenol does not seem to require renal innervation. An influence of alterations in glomerular filtration rate was also found not to be important in the antidiuretic effect associated with systemic beta adrenergic stimulation. In a number of individual experiments glomerular filtration rate actually increased during the intravenous infusion of isoproterenol, and in the group as a whole a small mean increase was observed (Table   I ). This finding established that a decrease in glomerular filtration rate leading to a diminution in distal fluid delivery is not a factor in the antidiuretic effect associated with intravenous isoproterenol.
The only significant and reversible alteration in renal hemodynamics which occurred during the intravenous infusion of isoproterenol was a small change in filtration fraction (Table I ). This increase in filtration fraction could have been due to the concomitant rise in arterial hematocrit (17, 24) . Recently, Schrier and Earley (17) have demonstrated that an increase in arterial hematocrit is associated with both an increase in filtration fraction and a decrease in solute-free water reabsorption, and it was suggested that these effects of hematocrit were due to an increase in postglomerular viscosity and enhanced sodium reabsorption in the proximal tubule, respectively. Micropuncture studies have recently confirmed that an increase in hematocrit is associated with an increase in proximal tubular reabsorption (25, 26) . However, in a quantitative sense, the small increase in hematocrit and filtration fraction that was observed in the present study during the intravenous infusion of isoproterenol would seem only to contribute in a very minor way to the resulting antidiuretic effect (17) .
The finding that alterations in renal hemodynamics and renal innervation did not contribute in any major way to the antidiuresis suggested an importance of either a direct effect of beta adrenergic stimulation on the renal tubular epithelial cell or an extrarenal reflex mechanism involving the release of ADH. Two approaches were used to differentiate between these two potential mechanisms. One approach was to examine the effect of intravenous isoproterenol on the water diuresis in animals in which the source of production and release of ADH had been ablated. The second approach was to investigate the effect of isoproterenol infused into the renal artery at a dose which was not associated with any systemic effects of the drug but yet delivered a concentration of drug to the renal circulation, which was at least as high as the renal arterial concentration achieved during the intravenous infusion of isoproterenol.
In the group of animals with ablation of the hypothalamo-neurohypophysial system, the intravenous infusion of isoproterenol was associated with no reversible effect on urinary osmolality. However, a small, reversible effect on free water clearance was observed in this group of animals. This small effect on free water clearance seemed most likely to be related to the effect of beta adrenergic stimulation to increase arterial hematocrit and filtration fraction. Although the changes in hematocrit and filtration fraction were similar in the normal animals and the animals with ablation of their hypothalamo-neurohypophysial tract, the antidiuretic effect was markedly different in these two groups of animal (Fig. 3) . This finding further supports the conclusion that any role of the increase in hematocrit in the antidiuretic effect is a relatively minor one. These results, however, primarily emphasize that the presence of an intact hypothalamo-neurohypophysial tract is of major importance in the antidiuretic effect of beta adrenergic stimulation. This conclusion of our studies in dogs is different from that of a recent preliminary communication in which the antidiuretic effect of intravenous isoproterenol was demonstrated to occur in rats with hereditary diabetes insipidus, and thus presumably with no endogenous production of ADH (27) . In these studies in rats the dose of isoproterenol was severalfold by body weight of the dose used in the present study. Although the effect of this larger dose of intravenous isoproterenol on systemic arterial pressure and renal hemodynamics was not reported, on the basis of the present results the relatively small increase in urinary osmolality which occurred in the diabetes insipidus rats (from 102 to 184 mOsm/kg H20) could have been due to effects on systemic and renal hemodynamics,
The present group of experiments in which isoproterenol was infused directly into the renal artery provided further support for the conclusion that the major antidiuretic effect of beta adrenergic stimulation is an extrarenal reflex mechanism. We found that doses of isoproterenol that markedly increased cardiac output and decreased total peripheral resistance when infused intravenously did not exert either of these effects on systemic hemodynamics when infused directly into the renal artery (Fig. 4) . The pathway(s) whereby the kidney so efficiently inactivates isoproterenol is currently under study in our laboratory. This efficient renal inactivation of the drug allowed us to examine the direct effect of intrarenal beta adrenergic stimulation on water diuresis in the absence of concomitant alterations in systemic hemodynamics. While previous investigators have infused isoproterenol into the renal artery (22, 23, 28) , in none of these studies have the systemic effects of the drug been adequately evaluated. In some of these studies arterial pressure has been shown to decrease (22, 23) while in other studies the arterial pressure has been unchanged during the intravenous administration of isoproterenol (28) . However, as demonstrated in the present study, arterial pressure may remain constant in the presence of substantial systemic effects of beta adrenergic stimulation to increase cardiac output and to decrease total peripheral resistance. In the present study the documentation of the absence of any systemic effects during the intrarenal infusion of the drug (which if present could potentially activate extrarenal reflex mechanism[s] and account for any observed effects on water diuresis) provided the experimental circumstance to examine the direct intrarenal effect of beta adrenergic stimulation on water diuresis. Since the concentration of isoproterenol in the renal circulation in these experiments would be con-siderably greater than the level achieved during the intravenous infusion of the drug,' the antidiuretic effect might be expected to be more pronounced if such an effect is due to a direct action of beta adrenergic stimulation on the renal tubular epithelial cell. No antidiuretic effect was observed, however, when isoproterenol was infused directly into the renal artery. In fact when the infused kidney was compared with its contralateral control kidney, the intrarenal isoproterenol was found to produce a relative increase in free water clearance. This finding is compatible with the recent results of Gill and Casper (28) ; however, in contrast to their results the effect on free water clearance found in our study was associated with parallel changes in glomerular filtration rate and renal vascular resistance when compared with the contralateral kidney ( Table III) .
The possibility should be considered that since isoproterenol is rapidly cleared by the kidney that the infused isoproterenol may not reach effective concentrations at any potential beta adrenergic receptor sites on either the luminal or peritubular border of the collecting duct. However, since the vasa recti surrounding collecting ducts derive directly from postglomerular arterioles without bathing cortical proximal and distal tubules, the concentration of drug in these vasa recti should be comparable with that reaching the glomerulus. In this regard preliminary studies withl radioisotopelabeled isoproterenol indicate that the clearance of the drug is at least comparable with the rate of glomerular filtration.4 This finding thus suggests that the drug reaches both the peritubular and luminal border of the collecting duct. Another possibility must also be considered that larger intrarenal doses of isoproterenol than used in the present experiments may be needed to alter tubular permeability. If so, such intrarenal beta adrenergic receptors must be much less sensitive than the beta adrenergic receptors in the heart and peripheral vasculature which were significantly stimulated during the intravenous infusion of isoproterenol in the present study. Moreover, the in vivo demonstration of such an insensitive intrarenal beta adrenergic receptor would be very difficult since larger intrarenal doses will produce systemic effects and thereby not allow the differentiation between an antidiuretic effect initiated by extrarenal vs. intrarenal pathways. ' In summary, the present results have demonstrated that an extrarenal reflex involving the integrity of the hypothalamo-neurohypophysial system and the release of ADH is primarily responsible for the antidiuretic effect of systemic beta adrenergic stimulation. The results also excluded a major role of alterations in renal hemodynamics or renal sympathetic tone in this antidiuretic response. Moreover, a dose of isoproterenol, which was associated with a marked stimulation of the cardiac beta adrenergic receptors when infused intravenously, was not found to produce an antidiuretic effect when infused directly into the renal artery. This latter result thus provided no support for a direct effect of beta adrenergic stimulation to increase the permeability to water of the renal tubular epithelium.
